147 related articles for article (PubMed ID: 34777523)
61. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
62. Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity.
Popat A; Karmakar S; Jambhrunkar S; Xu C; Yu C
Colloids Surf B Biointerfaces; 2014 May; 117():520-7. PubMed ID: 24698148
[TBL] [Abstract][Full Text] [Related]
63. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
[TBL] [Abstract][Full Text] [Related]
64. CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.
Ferrari A; Petterino C; Ratto A; Campanella C; Wurth R; Thellung S; Vito G; Barbieri F; Florio T
BMC Vet Res; 2012 Mar; 8():27. PubMed ID: 22417013
[TBL] [Abstract][Full Text] [Related]
65. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
[TBL] [Abstract][Full Text] [Related]
66. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo.
Moghtaderi H; Sepehri H; Attari F
Biomed Pharmacother; 2017 Apr; 88():582-594. PubMed ID: 28152473
[TBL] [Abstract][Full Text] [Related]
67. κ-Carrageenan: An effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis.
Sathuvan M; Thangam R; Gajendiran M; Vivek R; Balasubramanian S; Nagaraj S; Gunasekaran P; Madhan B; Rengasamy R
Carbohydr Polym; 2017 Mar; 160():184-193. PubMed ID: 28115093
[TBL] [Abstract][Full Text] [Related]
68. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line.
Jadid MFS; Shademan B; Chavoshi R; Seyyedsani N; Aghaei E; Taheri E; Goleij P; Hajazimian S; Karamad V; Behroozi J; Sabet MN; Isazadeh A; Baradaran B
Environ Toxicol; 2021 Jun; 36(6):1043-1051. PubMed ID: 33496383
[TBL] [Abstract][Full Text] [Related]
69. DK1 Induces Apoptosis via Mitochondria-Dependent Signaling Pathway in Human Colon Carcinoma Cell Lines In Vitro.
Hussin Y; Aziz MNM; Che Rahim NF; Yeap SK; Mohamad NE; Masarudin MJ; Nordin N; Abd Rahman NMA; Yong CY; Akhtar MN; Zamrus SNH; Alitheen NB
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641445
[TBL] [Abstract][Full Text] [Related]
70. Promotion of the anticancer activity of curcumin based on a metal-polyphenol networks delivery system.
Chen Y; Jia D; Wang Q; Sun Y; Rao Z; Lei X; Zhao J; Zeng K; Xu Z; Ming J
Int J Pharm; 2021 Jun; 602():120650. PubMed ID: 33957265
[TBL] [Abstract][Full Text] [Related]
71. A convergent synthetic platform for polymeric nanoparticle for the treatment of combination colorectal cancer therapy.
Zhang D; Jiang L; Liu C
J Biomater Sci Polym Ed; 2021 Oct; 32(14):1835-1848. PubMed ID: 34121628
[TBL] [Abstract][Full Text] [Related]
72. Curcumin Combined with Thalidomide Reduces Expression of
Mohammadi Kian M; Salemi M; Bahadoran M; Haghi A; Dashti N; Mohammadi S; Rostami S; Chahardouli B; Babakhani D; Nikbakht M
Drug Des Devel Ther; 2020; 14():185-194. PubMed ID: 32021103
[TBL] [Abstract][Full Text] [Related]
73. Glutathione-independent mechanism of apoptosis inhibition by curcumin in rat thymocytes.
Jaruga E; Bielak-Zmijewska A; Sikora E; Skierski J; Radziszewska E; Piwocka K; Bartosz G
Biochem Pharmacol; 1998 Oct; 56(8):961-5. PubMed ID: 9776306
[TBL] [Abstract][Full Text] [Related]
74. Synthesis and Characterization of Inhalable Flavonoid Nanoparticle for Lung Cancer Cell Targeting.
Lee WH; Loo CY; Ong HX; Traini D; Young PM; Rohanizadeh R
J Biomed Nanotechnol; 2016 Feb; 12(2):371-86. PubMed ID: 27305771
[TBL] [Abstract][Full Text] [Related]
75. Fe
Pazouki N; Irani S; Olov N; Atyabi SM; Bagheri-Khoulenjani S
Prog Biomater; 2022 Mar; 11(1):43-54. PubMed ID: 35025086
[TBL] [Abstract][Full Text] [Related]
76. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas.
Steuber N; Vo K; Wadhwa R; Birch J; Iacoban P; Chavez P; Elbayoumi TA
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792193
[TBL] [Abstract][Full Text] [Related]
77. Curcumin-coated gold nanoparticles attenuate doxorubicin-induced cardiotoxicity via regulating apoptosis in a mouse model.
Sharifiaghdam Z; Dalouchi F; Sharifiaghdam M; Shaabani E; Ramezani F; Nikbakht F; Azizi Y
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):70-83. PubMed ID: 34449914
[TBL] [Abstract][Full Text] [Related]
78. Curcumin Conjugates of Non-steroidal Anti-Inflammatory Drugs: Synthesis, Structures, Anti-proliferative Assays, Computational Docking, and Inflammatory Response.
Laali KK; Zwarycz AT; Beck N; Borosky GL; Nukaya M; Kennedy GD
ChemistryOpen; 2020 Aug; 9(8):822-834. PubMed ID: 32802728
[TBL] [Abstract][Full Text] [Related]
79. Tetrahydrocurcumin induces G2/M cell cycle arrest and apoptosis involving p38 MAPK activation in human breast cancer cells.
Kang N; Wang MM; Wang YH; Zhang ZN; Cao HR; Lv YH; Yang Y; Fan PH; Qiu F; Gao XM
Food Chem Toxicol; 2014 May; 67():193-200. PubMed ID: 24593988
[TBL] [Abstract][Full Text] [Related]
80. Targeted anticancer prodrug therapy using dextran mediated enzyme-antibody conjugate and β-cyclodextrin-curcumin inclusion complex.
Roozbehi S; Dadashzadeh S; Mirshahi M; Sadeghizadeh M; Sajedi RH
Int J Biol Macromol; 2020 Oct; 160():1029-1041. PubMed ID: 32479931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
